Candel Therapeutics NASDAQ:CADLCandel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.
Sep 02, 2025 Candel Therapeutics Appoints Renowned Immunotherapy Pioneer Carl H. June, M.D., to Research Advisory Board
At Candel Therapeutics, our team is developing viral immunotherapies that light up and empower the immune system to fight cancer
